Marie Rosenfeld is a strategic biotech executive with over two decades of experience leading clinical and business operations at Entrada Therapeutics, Astellas, and Abbott. She specializes in building and scaling high-performing teams in quantitative sciences to accelerate clinical development. Marie earned her Bachelor of Arts from Franklin & Marshall College.
Marie co-authored key clinical trial publications for Adalimumab (Humira) in Crohns Disease and Hidradenitis Suppurativa.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.